Departure from UK sends Netcare profit soaring

Interim net profit nearly doubled, and it declared a 16% increase in its dividend, after leaving a market that, in contrast to SA, is suffering waning demand

Finance chief to leave GSK after two transformational deals

The departure provides a further opportunity for GlaxoSmithKline CEO Emma Walmsley to stamp her imprint on Britain’s biggest drug maker

Takeda joins pharma giants with $62bn Shire deal

The Japanese firm plans to keep its headquarters in Osaka and may reduce the combined workforce by up to 7%

Aspen’s factory to create 500 jobs

New facility to produce specialised medicines for chronic conditions

Aspen aims to expand exports with opening of high-containment factory

About 95% of the new products will be exported to Latin America, Europe, Asia and Africa, with Europe having been the first to give its regulatory approval

WATCH: Why Dis-Chem is optimistic

Dis-Chem chief financial officer Rui Morais talks to Business Day TV about the company’s full-year results

Novo Nordisk profit gets a boost from diabetes onslaught

The Danish drug maker, the world’s biggest insulin supplier with 46% of the market, has increased its sales forecast

Life Healthcare’s shares rise after upbeat trading update

The hospital group says it expects to report that its basic earnings more than quadrupled in the six months to end-March

Mediclinic beats forecast

Things are looking better in the Middle East for the private healthcare group, though margins in Switzerland are being squeezed

Regulator gives Biovac green light to manufacture vaccines

Local vaccine manufacture brought in to try to improve security of supply for SA and the region

WATCH: What Life Healthcare plans to get done in 2018

CEO Dr Shrey Viranna talks to Business Day TV about the company’s business strategy

Bitter pill for drug makers as fees hike nears under new regulator

SA’s new medicines regulator, Sahpra, needs to overhaul its fee structure

Netcare to dispose of its UK interests

Netcare had done the right thing when it invested in the UK, but the market had changed dramatically since then, says CEO Richard Friedland

Healthcare services provider AfroCentric goes on the hunt

The group’s financial position remains sound, with strong cash generation

Netcare’s R1.3bn deal with Akeso gets regulatory approval

The deal goes through on condition that the new owners do not hike fees immediately

Pharma firm Ketlaphela has another shot at finding a partner

The state-owned pharmaceutical company invites partners to help it supply essential medicines to South Africa and the region

Subscribe to BL premium

Published by Tiso Blackstar and distributed with the Financial Mail on the last Thursday of every month except December and January.